Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition. [electronic resource] by
- Roth, Gerald J
- Heckel, Armin
- Kley, Jörg T
- Lehmann, Thorsten
- Müller, Stephan G
- Oost, Thorsten
- Rudolf, Klaus
- Arndt, Kirsten
- Budzinski, Ralph
- Lenter, Martin
- Lotz, Ralf R H
- Schindler, Marcus
- Thomas, Leo
- Stenkamp, Dirk
Producer: 20160412
In:
Bioorganic & medicinal chemistry letters vol. 25
Availability: No items available.
|
|
5.
|
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part III: Discovery of pre-clinical development candidate BI 186908. [electronic resource] by
- Oost, Thorsten
- Heckel, Armin
- Kley, Jörg T
- Lehmann, Thorsten
- Müller, Stephan
- Roth, Gerald J
- Rudolf, Klaus
- Arndt, Kirsten
- Budzinski, Ralph
- Lenter, Martin
- Lotz, Ralf R H
- Maier, Gerd-Michael
- Markert, Michael
- Thomas, Leo
- Stenkamp, Dirk
Producer: 20160412
In:
Bioorganic & medicinal chemistry letters vol. 25
Availability: No items available.
|
|
6.
|
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414. [electronic resource] by
- Müller, Stephan G
- Heckel, Armin
- Kley, Jörg T
- Lehmann, Thorsten
- Lustenberger, Philipp
- Oost, Thorsten
- Roth, Gerald J
- Rudolf, Klaus
- Arndt, Kirsten
- Lenter, Martin
- Lotz, Ralf R H
- Maier, Gerd-Michael
- Markert, Michael
- Schindler, Marcus
- Stenkamp, Dirk
Producer: 20160412
In:
Bioorganic & medicinal chemistry letters vol. 25
Availability: No items available.
|